JAK Inhibitors Show No Excess CV Safety Signal
Compared with adalimumab, JAK inhibitors presented no higher risk for major adverse cardiovascular events or venous thromboembolism in patients with rheumatoid arthritis.
Source: medscape.com
Warnings Encourage Caution News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Warnings Encourage Caution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Warnings Encourage Caution Today - Breaking & Trending Today